首页> 外文期刊>Movement disorders >Is executive control used to compensate for involuntary movements in levodopa-induced dyskinesia?
【24h】

Is executive control used to compensate for involuntary movements in levodopa-induced dyskinesia?

机译:执行控制是否用于补偿左旋多巴引起的运动障碍的不自主运动?

获取原文
获取原文并翻译 | 示例
           

摘要

Levodopa (L-dopa)-induced dyskinesia (LID) emerge in the majority of PD patients after long-term L-dopa treatment. LID most often coincide with the maximal antiparkinsonian effect of L-dopa ("peak dose or ondyskinesias") and are mainly choreiform in nature. Though the precise mechanism responsible for the development of LID is still unclear, the pathophysiology apparently involves a change in the firing patterns that signal between the basal ganglia and the cortex, leading to overactivation of motor frontal areas. Two recent neuroimaging studies published in this journal provide new information about the relationship between cortical function and LID.
机译:长期左旋多巴治疗后,大多数PD患者会出现左旋多巴(左旋多巴)引起的运动障碍(LID)。 LID通常与左旋多巴的最大抗帕金森病作用(“峰值剂量或运动障碍”)一致,并且在自然界中主要呈编排状。尽管尚不清楚导致LID发生的确切机制,但病理生理学显然涉及到在基底神经节和皮层之间发出信号的放电方式的改变,从而导致运动额叶区域的过度活化。该杂志上发表的两项最新的神经影像学研究提供了有关皮质功能与LID之间关系的新信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号